The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Oconnell Daniel Joseph since 2021.
This trader's CIK number is 1865136.
At the time of last reporting, Oconnell Daniel Joseph was the Chief Executive Officer of Acumen Pharmaceuticals, Inc.. (stock ticker symbol ABOS).
Also see all insider trading activities at Acumen Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ABOS | 0 | $0 | 47,778 | $87,863 | 0 | $0 |
| 2024 | ABOS | 0 | $0 | 15,200 | $52,759 | 0 | $0 |
| 2021 | ABOS | 0 | $0 | 0 | $0 | 1,118 | $4,997 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | ABOS | Sale | 47,778 | 1.84 | 87,863 |
| 2024-01-19 | ABOS | Sale | 15,200 | 3.47 | 52,759 |
| 2021-11-30 | ABOS | Option Ex | 1,118 | 4.47 | 4,997 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oconnell Daniel Joseph (Chief Executive Officer of Acumen Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.